Cabot Co. (NYSE:CBT) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Cabot Co. (NYSE:CBT - Free Report) by 18.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 117,974 shares of the specialty chemicals company's stock after acquiring an additional 18,021 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.22% of Cabot worth $10,772,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of CBT. R Squared Ltd acquired a new position in Cabot in the 4th quarter valued at $26,000. EverSource Wealth Advisors LLC grew its position in Cabot by 37.2% in the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock worth $74,000 after acquiring an additional 219 shares during the period. Manchester Capital Management LLC increased its position in shares of Cabot by 1,685.1% during the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock worth $153,000 after purchasing an additional 1,584 shares during the last quarter. KBC Group NV raised its stake in shares of Cabot by 43.1% in the 4th quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company's stock valued at $187,000 after acquiring an additional 616 shares during the period. Finally, Measured Wealth Private Client Group LLC acquired a new position in Cabot during the fourth quarter worth $205,000. Institutional investors and hedge funds own 93.18% of the company's stock.

Cabot Stock Performance

Shares of NYSE:CBT traded up $1.56 during trading on Tuesday, reaching $75.59. The company had a trading volume of 132,620 shares, compared to its average volume of 409,501. Cabot Co. has a fifty-two week low of $71.64 and a fifty-two week high of $117.46. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29. The stock's fifty day moving average price is $77.41 and its 200 day moving average price is $86.96. The firm has a market capitalization of $4.06 billion, a price-to-earnings ratio of 10.04, a price-to-earnings-growth ratio of 0.74 and a beta of 0.91.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.04. The company had revenue of $936.00 million for the quarter, compared to analysts' expectations of $1.02 billion. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Cabot's revenue was down 8.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.78 EPS. As a group, equities research analysts predict that Cabot Co. will post 7.57 EPS for the current year.

Cabot Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 30th will be issued a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 2.38%. The ex-dividend date of this dividend is Friday, May 30th. This is a positive change from Cabot's previous quarterly dividend of $0.43. Cabot's payout ratio is currently 23.29%.

Wall Street Analyst Weigh In

Several research firms have recently commented on CBT. UBS Group lowered their price objective on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a research note on Monday, April 7th. JPMorgan Chase & Co. reduced their target price on Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a report on Friday, February 21st. Finally, Wall Street Zen lowered Cabot from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.